CDKN1B and breast cancer: However, other genetic variants of CDKN1B have been associated with other tumours such as prostate cancer 34, oral squamous cell carcinoma 35, invasive epithelial ovarian cancer 36, high‐grade breast tumour 37 and lymph node metastasis in breast cancer 38.